Raptor Pharmaceuticals Corp. was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.73 to $6.89 over the past one month time frame.

This Med/Biomed gene industry stock witnessed one positive estimate revision over the past 30 days. The Zacks Consensus Estimate also moved up over the same time frame, suggesting that more solid trading could be ahead for Raptor Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Raptor Pharmaceuticals has a Zacks Rank #2 (Buy).

RAPTOR PHARMACT Price

 

RAPTOR PHARMACT Price | RAPTOR PHARMACT Quote

Investors interested in the space may also consider Actelion Ltd. , sporting a Zacks Rank #1 (Strong Buy).

Is RPTP going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>